Chronic Lymphocytic Leukemia (CLL) research hub

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

This study is testing a new medicine, NX-5948, for adults with certain types of blood cancer that have come back or not responded well to previous treatments. It aims to find out if the medicine is safe and helps fight the cancer, starting with small doses and gradually increasing.